0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Urology Drugs Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-6T8081
Home | Market Reports | Health| Pharmacy
Global Urology Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Urology Drugs Market Research Report 2023

Code: QYRE-Auto-6T8081
Report
March 2023
Pages:65
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Urology Drugs Market

The global Urology Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Urology Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Urology Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Urology Drugs include Astellas, Endo, GP Pharm and Tolmar, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Urology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urology Drugs.
The Urology Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Urology Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urology Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Astellas
  • Endo
  • GP Pharm
  • Tolmar

Segment by Type

  • Α (alpha) Blockers
  • 5 α-reductase Inhibitors

Segment by Application

  • Hospital
  • Clinic
  • Others

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Urology Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Urology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Urology Drugs Market Report

Report MetricDetails
Report NameGlobal Urology Drugs Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Urology Drugs Market Overview
1.1 Product Overview and Scope of Urology Drugs
1.2 Urology Drugs Segment by Type
1.2.1 Global Urology Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Α (alpha) Blockers
1.2.3 5 α-reductase Inhibitors
1.3 Urology Drugs Segment by Application
1.3.1 Global Urology Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Urology Drugs Market Size Estimates and Forecasts
1.4.1 Global Urology Drugs Revenue 2018-2029
1.4.2 Global Urology Drugs Sales 2018-2029
1.4.3 Global Urology Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Urology Drugs Market Competition by Manufacturers
2.1 Global Urology Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Urology Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Urology Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Urology Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Urology Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Urology Drugs, Product Type & Application
2.7 Urology Drugs Market Competitive Situation and Trends
2.7.1 Urology Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Urology Drugs Players Market Share by Revenue
2.7.3 Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Urology Drugs Retrospective Market Scenario by Region
3.1 Global Urology Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Urology Drugs Global Urology Drugs Sales by Region: 2018-2029
3.2.1 Global Urology Drugs Sales by Region: 2018-2023
3.2.2 Global Urology Drugs Sales by Region: 2024-2029
3.3 Global Urology Drugs Global Urology Drugs Revenue by Region: 2018-2029
3.3.1 Global Urology Drugs Revenue by Region: 2018-2023
3.3.2 Global Urology Drugs Revenue by Region: 2024-2029
3.4 North America Urology Drugs Market Facts & Figures by Country
3.4.1 North America Urology Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Urology Drugs Sales by Country (2018-2029)
3.4.3 North America Urology Drugs Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Urology Drugs Market Facts & Figures by Country
3.5.1 Europe Urology Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Urology Drugs Sales by Country (2018-2029)
3.5.3 Europe Urology Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Urology Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Urology Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Urology Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Urology Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Urology Drugs Market Facts & Figures by Country
3.7.1 Latin America Urology Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Urology Drugs Sales by Country (2018-2029)
3.7.3 Latin America Urology Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Urology Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Urology Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Urology Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Urology Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Urology Drugs Sales by Type (2018-2029)
4.1.1 Global Urology Drugs Sales by Type (2018-2023)
4.1.2 Global Urology Drugs Sales by Type (2024-2029)
4.1.3 Global Urology Drugs Sales Market Share by Type (2018-2029)
4.2 Global Urology Drugs Revenue by Type (2018-2029)
4.2.1 Global Urology Drugs Revenue by Type (2018-2023)
4.2.2 Global Urology Drugs Revenue by Type (2024-2029)
4.2.3 Global Urology Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Urology Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Urology Drugs Sales by Application (2018-2029)
5.1.1 Global Urology Drugs Sales by Application (2018-2023)
5.1.2 Global Urology Drugs Sales by Application (2024-2029)
5.1.3 Global Urology Drugs Sales Market Share by Application (2018-2029)
5.2 Global Urology Drugs Revenue by Application (2018-2029)
5.2.1 Global Urology Drugs Revenue by Application (2018-2023)
5.2.2 Global Urology Drugs Revenue by Application (2024-2029)
5.2.3 Global Urology Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Urology Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Astellas
6.1.1 Astellas Corporation Information
6.1.2 Astellas Description and Business Overview
6.1.3 Astellas Urology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Astellas Urology Drugs Product Portfolio
6.1.5 Astellas Recent Developments/Updates
6.2 Endo
6.2.1 Endo Corporation Information
6.2.2 Endo Description and Business Overview
6.2.3 Endo Urology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Endo Urology Drugs Product Portfolio
6.2.5 Endo Recent Developments/Updates
6.3 GP Pharm
6.3.1 GP Pharm Corporation Information
6.3.2 GP Pharm Description and Business Overview
6.3.3 GP Pharm Urology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GP Pharm Urology Drugs Product Portfolio
6.3.5 GP Pharm Recent Developments/Updates
6.4 Tolmar
6.4.1 Tolmar Corporation Information
6.4.2 Tolmar Description and Business Overview
6.4.3 Tolmar Urology Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Tolmar Urology Drugs Product Portfolio
6.4.5 Tolmar Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Urology Drugs Industry Chain Analysis
7.2 Urology Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Urology Drugs Production Mode & Process
7.4 Urology Drugs Sales and Marketing
7.4.1 Urology Drugs Sales Channels
7.4.2 Urology Drugs Distributors
7.5 Urology Drugs Customers
8 Urology Drugs Market Dynamics
8.1 Urology Drugs Industry Trends
8.2 Urology Drugs Market Drivers
8.3 Urology Drugs Market Challenges
8.4 Urology Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Urology Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Urology Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Urology Drugs Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Urology Drugs Sales (MT) of Key Manufacturers (2018-2023)
    Table 5. Global Urology Drugs Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Urology Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Urology Drugs Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Urology Drugs Average Price (USD/Kg) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Urology Drugs, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Urology Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Urology Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Urology Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Urology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urology Drugs as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Urology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Urology Drugs Sales by Region (2018-2023) & (MT)
    Table 18. Global Urology Drugs Sales Market Share by Region (2018-2023)
    Table 19. Global Urology Drugs Sales by Region (2024-2029) & (MT)
    Table 20. Global Urology Drugs Sales Market Share by Region (2024-2029)
    Table 21. Global Urology Drugs Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Urology Drugs Revenue Market Share by Region (2018-2023)
    Table 23. Global Urology Drugs Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Urology Drugs Revenue Market Share by Region (2024-2029)
    Table 25. North America Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Urology Drugs Sales by Country (2018-2023) & (MT)
    Table 27. North America Urology Drugs Sales by Country (2024-2029) & (MT)
    Table 28. North America Urology Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Urology Drugs Sales by Country (2018-2023) & (MT)
    Table 32. Europe Urology Drugs Sales by Country (2024-2029) & (MT)
    Table 33. Europe Urology Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Urology Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Urology Drugs Sales by Region (2018-2023) & (MT)
    Table 37. Asia Pacific Urology Drugs Sales by Region (2024-2029) & (MT)
    Table 38. Asia Pacific Urology Drugs Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Urology Drugs Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Urology Drugs Sales by Country (2018-2023) & (MT)
    Table 42. Latin America Urology Drugs Sales by Country (2024-2029) & (MT)
    Table 43. Latin America Urology Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Urology Drugs Sales by Country (2018-2023) & (MT)
    Table 47. Middle East & Africa Urology Drugs Sales by Country (2024-2029) & (MT)
    Table 48. Middle East & Africa Urology Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Urology Drugs Sales (MT) by Type (2018-2023)
    Table 51. Global Urology Drugs Sales (MT) by Type (2024-2029)
    Table 52. Global Urology Drugs Sales Market Share by Type (2018-2023)
    Table 53. Global Urology Drugs Sales Market Share by Type (2024-2029)
    Table 54. Global Urology Drugs Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Urology Drugs Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Urology Drugs Revenue Market Share by Type (2018-2023)
    Table 57. Global Urology Drugs Revenue Market Share by Type (2024-2029)
    Table 58. Global Urology Drugs Price (USD/Kg) by Type (2018-2023)
    Table 59. Global Urology Drugs Price (USD/Kg) by Type (2024-2029)
    Table 60. Global Urology Drugs Sales (MT) by Application (2018-2023)
    Table 61. Global Urology Drugs Sales (MT) by Application (2024-2029)
    Table 62. Global Urology Drugs Sales Market Share by Application (2018-2023)
    Table 63. Global Urology Drugs Sales Market Share by Application (2024-2029)
    Table 64. Global Urology Drugs Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Urology Drugs Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Urology Drugs Revenue Market Share by Application (2018-2023)
    Table 67. Global Urology Drugs Revenue Market Share by Application (2024-2029)
    Table 68. Global Urology Drugs Price (USD/Kg) by Application (2018-2023)
    Table 69. Global Urology Drugs Price (USD/Kg) by Application (2024-2029)
    Table 70. Astellas Corporation Information
    Table 71. Astellas Description and Business Overview
    Table 72. Astellas Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 73. Astellas Urology Drugs Product
    Table 74. Astellas Recent Developments/Updates
    Table 75. Endo Corporation Information
    Table 76. Endo Description and Business Overview
    Table 77. Endo Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 78. Endo Urology Drugs Product
    Table 79. Endo Recent Developments/Updates
    Table 80. GP Pharm Corporation Information
    Table 81. GP Pharm Description and Business Overview
    Table 82. GP Pharm Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 83. GP Pharm Urology Drugs Product
    Table 84. GP Pharm Recent Developments/Updates
    Table 85. Tolmar Corporation Information
    Table 86. Tolmar Description and Business Overview
    Table 87. Tolmar Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
    Table 88. Tolmar Urology Drugs Product
    Table 89. Tolmar Recent Developments/Updates
    Table 90. Key Raw Materials Lists
    Table 91. Raw Materials Key Suppliers Lists
    Table 92. Urology Drugs Distributors List
    Table 93. Urology Drugs Customers List
    Table 94. Urology Drugs Market Trends
    Table 95. Urology Drugs Market Drivers
    Table 96. Urology Drugs Market Challenges
    Table 97. Urology Drugs Market Restraints
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Urology Drugs
    Figure 2. Global Urology Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Urology Drugs Market Share by Type in 2022 & 2029
    Figure 4. Α (alpha) Blockers Product Picture
    Figure 5. 5 α-reductase Inhibitors Product Picture
    Figure 6. Global Urology Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Urology Drugs Market Share by Application in 2022 & 2029
    Figure 8. Hospital
    Figure 9. Clinic
    Figure 10. Others
    Figure 11. Global Urology Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Urology Drugs Market Size (2018-2029) & (US$ Million)
    Figure 13. Global Urology Drugs Sales (2018-2029) & (MT)
    Figure 14. Global Urology Drugs Average Price (USD/Kg) & (2018-2029)
    Figure 15. Urology Drugs Report Years Considered
    Figure 16. Urology Drugs Sales Share by Manufacturers in 2022
    Figure 17. Global Urology Drugs Revenue Share by Manufacturers in 2022
    Figure 18. The Global 5 and 10 Largest Urology Drugs Players: Market Share by Revenue in 2022
    Figure 19. Urology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 20. Global Urology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 21. North America Urology Drugs Sales Market Share by Country (2018-2029)
    Figure 22. North America Urology Drugs Revenue Market Share by Country (2018-2029)
    Figure 23. U.S. Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 24. Canada Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Europe Urology Drugs Sales Market Share by Country (2018-2029)
    Figure 26. Europe Urology Drugs Revenue Market Share by Country (2018-2029)
    Figure 27. Germany Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. France Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. U.K. Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Italy Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Russia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Asia Pacific Urology Drugs Sales Market Share by Region (2018-2029)
    Figure 33. Asia Pacific Urology Drugs Revenue Market Share by Region (2018-2029)
    Figure 34. China Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Japan Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. South Korea Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. India Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Australia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Taiwan Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Indonesia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Thailand Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Malaysia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Philippines Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Latin America Urology Drugs Sales Market Share by Country (2018-2029)
    Figure 45. Latin America Urology Drugs Revenue Market Share by Country (2018-2029)
    Figure 46. Mexico Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Brazil Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Argentina Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa Urology Drugs Sales Market Share by Country (2018-2029)
    Figure 50. Middle East & Africa Urology Drugs Revenue Market Share by Country (2018-2029)
    Figure 51. Turkey Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. U.A.E Urology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Global Sales Market Share of Urology Drugs by Type (2018-2029)
    Figure 55. Global Revenue Market Share of Urology Drugs by Type (2018-2029)
    Figure 56. Global Urology Drugs Price (USD/Kg) by Type (2018-2029)
    Figure 57. Global Sales Market Share of Urology Drugs by Application (2018-2029)
    Figure 58. Global Revenue Market Share of Urology Drugs by Application (2018-2029)
    Figure 59. Global Urology Drugs Price (USD/Kg) by Application (2018-2029)
    Figure 60. Urology Drugs Value Chain
    Figure 61. Urology Drugs Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Oral Mucositis Drugs Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-5A8986
Sat Sep 23 00:00:00 UTC 2023

Add to Cart

Global Subcutaneous Immunoglobulins Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-38X9072
Sat Sep 23 00:00:00 UTC 2023

Add to Cart

Global Urokinase Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-24Z9012
Sat Sep 23 00:00:00 UTC 2023

Add to Cart

Global Hyperimmune Globulins Market Insights, Forecast to 2029

120 Pages
Type: Report
Code: QYRE-Auto-13I9059
Sat Sep 23 00:00:00 UTC 2023

Add to Cart